Signaling Pathways of Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 30 August 2024 | Viewed by 3018
Special Issue Editors
Interests: breast cancer; bone metastases; drug resistance; RANKL-RANK pathway
Special Issue Information
Dear Colleagues,
Breast cancer is the most common malignancy worldwide. Its heterogeneous etiology, histology and molecular profile are translated into distinct intrinsic sub-types, associated with different types of biology and prognoses.
Major breakthroughs in breast cancer treatment were fueled by targeted therapies, with the most striking being the endocrine and anti-HER2 therapies and, more recently, the CDK4/6 inhibitors. However, intrinsic and acquired resistance are almost inevitable.
By increasing our knowledge about the signaling pathways involved in major breast cancer hallmarks, about their crosstalk and target ability, and about their role in response to standard of care or new therapies, we may envisage an improvement in the prognosis of breast cancer patients.
This Special Issue of Cancers intends to gather new breakthrough research, focusing on the multiple aspects and relevance of signaling pathways in breast cancer.
Prof. Dr. Sandra Casimiro
Dr. Marta Martins
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Breast cancer
- signal transduction
- targeted therapies
- resistance to therapy
- novel molecular mechanisms
